Stéphane heads Deloitte's Life Sciences practice for France and Central Europe. As a Life Sciences advisor, he brings extensive expertise in optimizing the value of life sciences products, guiding strategic decision-making to ensure superior value recognition and favorable access conditions, spanning from indication selection and clinical development plan design to market access and pricing strategies.Notably, Stéphane is dedicated to supporting top-tier pharmaceutical companies in enhancing their social impact, with a particular focus on fostering access to medicine. His collaborative approach empowers organizations to make a tangible difference by facilitating the availability of essential treatments to those in need.